Bingxin Zheng

1.7k total citations
26 papers, 1.3k citations indexed

About

Bingxin Zheng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Bingxin Zheng has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Bingxin Zheng's work include Sarcoma Diagnosis and Treatment (6 papers), Autophagy in Disease and Therapy (5 papers) and MicroRNA in disease regulation (4 papers). Bingxin Zheng is often cited by papers focused on Sarcoma Diagnosis and Treatment (6 papers), Autophagy in Disease and Therapy (5 papers) and MicroRNA in disease regulation (4 papers). Bingxin Zheng collaborates with scholars based in China and Macao. Bingxin Zheng's co-authors include Yi Huang, Tingting Ren, Kuisheng Liu, Xing Bao, Shidong Wang, Kunkun Sun, Wei Guo, Wei Guo, Qingqing Zhang and Wenzhuo Zhuang and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Chemistry and Cancer Research.

In The Last Decade

Bingxin Zheng

25 papers receiving 1.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Bingxin Zheng 639 454 376 327 268 26 1.3k
Jason R. Pitarresi 959 1.5× 830 1.8× 467 1.2× 256 0.8× 358 1.3× 36 1.8k
Zheng Gong 825 1.3× 422 0.9× 377 1.0× 126 0.4× 371 1.4× 42 1.5k
Ling Cen 626 1.0× 569 1.3× 197 0.5× 151 0.5× 251 0.9× 44 1.3k
Uthra Balaji 683 1.1× 1.1k 2.4× 661 1.8× 271 0.8× 208 0.8× 24 1.6k
Quintin Pan 1.2k 1.8× 631 1.4× 442 1.2× 163 0.5× 146 0.5× 44 1.8k
Daqing Wu 942 1.5× 460 1.0× 279 0.7× 329 1.0× 167 0.6× 56 1.7k
Yao Yuan 855 1.3× 500 1.1× 376 1.0× 185 0.6× 174 0.6× 72 1.6k
Xinxin Zhang 684 1.1× 517 1.1× 318 0.8× 436 1.3× 229 0.9× 76 1.5k
Mahshid Deldar Abad Paskeh 1.0k 1.6× 210 0.5× 650 1.7× 188 0.6× 114 0.4× 33 1.5k
Guanmin Jiang 675 1.1× 399 0.9× 242 0.6× 100 0.3× 296 1.1× 19 1.2k

Countries citing papers authored by Bingxin Zheng

Since Specialization
Citations

This map shows the geographic impact of Bingxin Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingxin Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingxin Zheng more than expected).

Fields of papers citing papers by Bingxin Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingxin Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingxin Zheng. The network helps show where Bingxin Zheng may publish in the future.

Co-authorship network of co-authors of Bingxin Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Bingxin Zheng. A scholar is included among the top collaborators of Bingxin Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingxin Zheng. Bingxin Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Mengling, Bingxin Zheng, Bangshun He, et al.. (2025). Advanced nucleic acid probes for enhanced CRISPR diagnostics. TrAC Trends in Analytical Chemistry. 194. 118496–118496.
2.
3.
Zhang, Ranran, Zichao Yan, Ming Gao, et al.. (2024). Recent advances in two-dimensional materials for drug delivery. Journal of Materials Chemistry B. 12(48). 12437–12469. 9 indexed citations
4.
Zheng, Bingxin, Ranran Zhang, Fei Kuang, et al.. (2024). Schottky heterojunction CeO2@MXene nanosheets with synergistic type I and type II PDT for anti-osteosarcoma. Journal of Materials Chemistry B. 12(7). 1816–1825. 18 indexed citations
5.
Zheng, Bingxin, Tao Li, Zhichen Xu, et al.. (2024). Hydrophilic/hydrophobic modified microchip for detecting multiple gene doping candidates using CRISPR-Cas12a and RPA. Biosensors and Bioelectronics. 263. 116631–116631. 5 indexed citations
6.
Deng, Shun, Yunyang Zhao, Hao Guo, et al.. (2024). Graphene oxide quantum dots (GOQDs) induce behavioral disorders via the disturbance of kynurenine pathway in zebrafish larvae. Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology. 279. 109865–109865. 3 indexed citations
7.
Yao, Ke, Bingxin Zheng, Xuxiang Wang, et al.. (2023). Osteoclast Cancer Cell Metabolic Cross-talk Confers PARP Inhibitor Resistance in Bone Metastatic Breast Cancer. Cancer Research. 84(3). 449–467. 14 indexed citations
8.
Zheng, Bingxin, Lingling Sun, Yang Gao, et al.. (2022). Siglec-15-induced autophagy promotes invasion and metastasis of human osteosarcoma cells by activating the epithelial–mesenchymal transition and Beclin-1/ATG14 pathway. Cell & Bioscience. 12(1). 109–109. 8 indexed citations
9.
10.
Xie, Lu, Jie Xu, Xin Sun, et al.. (2020). Apatinib plus camrelizumab (anti-PD1 therapy, SHR-1210) for advanced osteosarcoma (APFAO) progressing after chemotherapy: a single-arm, open-label, phase 2 trial. Journal for ImmunoTherapy of Cancer. 8(1). e000798–e000798. 95 indexed citations
11.
Zheng, Bingxin, et al.. (2020). VEGFR2 Promotes Metastasis and PD-L2 Expression of Human Osteosarcoma Cells by Activating the STAT3 and RhoA-ROCK-LIMK2 Pathways. Frontiers in Oncology. 10. 543562–543562. 27 indexed citations
12.
Wang, Jun, Hongliang Zhang, Xin Sun, et al.. (2020). Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients. Journal of Nanobiotechnology. 18(1). 151–151. 74 indexed citations
13.
Ren, Tingting, Bingxin Zheng, Yi Huang, et al.. (2019). Osteosarcoma cell intrinsic PD-L2 signals promote invasion and metastasis via the RhoA-ROCK-LIMK2 and autophagy pathways. Cell Death and Disease. 10(4). 261–261. 64 indexed citations
14.
Han, Yu, Wei Guo, Tingting Ren, et al.. (2018). Tumor-associated macrophages promote lung metastasis and induce epithelial-mesenchymal transition in osteosarcoma by activating the COX-2/STAT3 axis. Cancer Letters. 440-441. 116–125. 144 indexed citations
15.
Zhang, Fan, Taiqiang Yan, Wei Guo, et al.. (2018). Novel oncogene COPS3 interacts with Beclin1 and Raf-1 to regulate metastasis of osteosarcoma through autophagy. Journal of Experimental & Clinical Cancer Research. 37(1). 135–135. 46 indexed citations
16.
Zheng, Bingxin, Tingting Ren, Yi Huang, et al.. (2018). PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse. Journal of Hematology & Oncology. 11(1). 16–16. 114 indexed citations
17.
Liu, Kuisheng, Tingting Ren, Yi Huang, et al.. (2017). Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma. Cell Death and Disease. 8(8). e3015–e3015. 229 indexed citations
18.
Bao, Xing, Tingting Ren, Yi Huang, et al.. (2017). Knockdown of long non-coding RNA HOTAIR increases miR-454-3p by targeting Stat3 and Atg12 to inhibit chondrosarcoma growth. Cell Death and Disease. 8(2). e2605–e2605. 93 indexed citations
19.
Bao, Xing, Tingting Ren, Yi Huang, et al.. (2016). Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma. Journal of Experimental & Clinical Cancer Research. 35(1). 129–129. 17 indexed citations
20.
Zhuang, Wenzhuo, Linmei Long, Bingxin Zheng, et al.. (2011). Curcumin promotes differentiation of glioma‐initiating cells by inducing autophagy. Cancer Science. 103(4). 684–690. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason R. Pitarresi Breakdown of academic impact, for papers by Zheng Gong Breakdown of academic impact, for papers by Ling Cen Breakdown of academic impact, for papers by Uthra Balaji Breakdown of academic impact, for papers by Quintin Pan Breakdown of academic impact, for papers by Daqing Wu Breakdown of academic impact, for papers by Yao Yuan Breakdown of academic impact, for papers by Xinxin Zhang Breakdown of academic impact, for papers by Mahshid Deldar Abad Paskeh Breakdown of academic impact, for papers by Guanmin Jiang
Rankless by CCL
2026